Responding to Wound Care Audits and Skin Substitute Audits in 2026
CMS UPDATE – DECEMBER 24, 2025 “Effective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers that were scheduled to become effective on January 1, 2026.” ORIGINAL ARTICLE (December 11, 2025): In 1789, […]
Responding to Wound Care Audits and Skin Substitute Audits in 2026 Read More »



You must be logged in to post a comment.